Accolade Announces Upcoming Investor Events
Get Alerts ACCD Hot Sheet
Join SI Premium – FREE
SEATTLE, May 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the following upcoming investor events. A webcast and replay of each event will be available at ir.accolade.com.
- Monday, May 8 at 1:00 pm PT. Accolade’s Capital Markets Day at the Wynn Las Vegas
- Tuesday, May 9 at 3:40 pm PT. BofA Securities Health Care Conference 2023 at the Encore Hotel in Las Vegas
About Accolade, Inc.
Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedIn, Twitter, Instagram and Facebook.
Investor Contact:
Todd Friedman, Investor Relations, [email protected]
Source: Accolade
Source: Accolade, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zacatecas Silver Announces Non-Brokered Private Placement of up to $2,500,000 to Advance Oso Negro Drill Program
- Orezone Reports Q2 2026 Production and Provides Casa Berardi Operations Update
- Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share